NB2 Fundamental Analysis - NORTHERN DATA AG

Fundamental Rating

Overall NB2 gets a fundamental rating of 3 out of 10. We evaluated NB2 against 116 industry peers in the Software industry. NB2 has a bad profitability rating. Also its financial health evaluation is rather negative. NB2 is valued quite expensively, but it does show have an excellent growth rating.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year NB2 has reported negative net income.

NB2 had a negative operating cash flow in the past year.

In the past 5 years NB2 reported 4 times negative net income.

In multiple years NB2 reported negative operating cash flow during the last 5 years.

1.2 Ratios

NB2 has a Return On Assets of -5.08%. This is in the lower half of the industry: NB2 underperforms 70.69% of its industry peers.

Looking at the Return On Equity, with a value of -10.03%, NB2 is doing worse than 67.24% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-5.08%
ROE	-10.03%
ROIC	N/A

ROA(3y)-27.09%

ROA(5y)-12.41%

ROE(3y)-36.56%

ROE(5y)-22.1%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 37.20%, NB2 is doing worse than 81.03% of the companies in the same industry.

In the last couple of years the Gross Margin of NB2 has grown nicely.

NB2 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	37.2%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y9.08%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NB2 does not have a ROIC to compare to the WACC, probably because it is not profitable.

NB2 has more shares outstanding than it did 1 year ago.

The number of shares outstanding for NB2 has been increased compared to 5 years ago.

Compared to 1 year ago, NB2 has a worse debt to assets ratio.

2.2 Solvency

NB2 has an Altman-Z score of 1.44. This is a bad value and indicates that NB2 is not financially healthy and even has some risk of bankruptcy.

NB2 has a worse Altman-Z score (1.44) than 67.24% of its industry peers.

A Debt/Equity ratio of 0.82 indicates that NB2 is somewhat dependend on debt financing.

NB2 has a Debt to Equity ratio of 0.82. This is in the lower half of the industry: NB2 underperforms 75.86% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.82
Debt/FCF	N/A
Altman-Z	1.44

ROIC/WACCN/A

WACC7.37%

2.3 Liquidity

NB2 has a Current Ratio of 2.69. This indicates that NB2 is financially healthy and has no problem in meeting its short term obligations.

NB2 has a better Current ratio (2.69) than 83.62% of its industry peers.

A Quick Ratio of 2.69 indicates that NB2 has no problem at all paying its short term obligations.

NB2 has a Quick ratio of 2.69. This is amongst the best in the industry. NB2 outperforms 83.62% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.69
Quick Ratio	2.69

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

NB2 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -480.00%.

The Revenue has grown by 61.65% in the past year. This is a very strong growth!

Measured over the past years, NB2 shows a very strong growth in Revenue. The Revenue has been growing by 81.52% on average per year.

EPS 1Y (TTM)-480%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-413.7%

Revenue 1Y (TTM)61.65%

Revenue growth 3Y1.8%

Revenue growth 5Y81.52%

Sales Q2Q%72.47%

3.2 Future

NB2 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.04% yearly.

The Revenue is expected to grow by 23.74% on average over the next years. This is a very strong growth

EPS Next Y-21.37%

EPS Next 2Y22.06%

EPS Next 3Y29.04%

EPS Next 5YN/A

Revenue Next Year13.21%

Revenue Next 2Y38.36%

Revenue Next 3Y34.68%

Revenue Next 5Y23.74%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

NB2 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NB2. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

NB2's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NB2 is cheaper than 75.86% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	12.34

4.3 Compensation for Growth

NB2's earnings are expected to grow with 29.04% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y22.06%

EPS Next 3Y29.04%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

NB2 does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NORTHERN DATA AG

FRA:NB2 (12/3/2025, 7:00:00 PM)

14.92

+0.07 (+0.47%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)10-16 2025-10-16

Earnings (Next)03-26 2026-03-26/amc

Inst Owners3.18%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap957.86M

Revenue(TTM)16.38M

Net Income(TTM)-84.26M

Analysts82.22

Price Target32.23 (116.02%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-7.06%

PT rev (3m)-13.66%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-13.16%

EPS NY rev (3m)-87.02%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-8.11%

Revenue NY rev (3m)-15.71%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	58.49
P/FCF	N/A
P/OCF	N/A
P/B	1.14
P/tB	1.19
EV/EBITDA	12.34

EPS(TTM)-7.25

EYN/A

EPS(NY)-2.47

Fwd EYN/A

FCF(TTM)-16.3

FCFYN/A

OCF(TTM)-0.91

OCFYN/A

SpS0.26

BVpS13.08

TBVpS12.51

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-5.08%
ROE	-10.03%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	37.2%
FCFM	N/A

ROA(3y)-27.09%

ROA(5y)-12.41%

ROE(3y)-36.56%

ROE(5y)-22.1%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y9.08%

GM growth 5YN/A

F-Score3

Asset Turnover0.01

Health

		Industry Rank	Sector Rank
Debt/Equity	0.82
Debt/FCF	N/A
Debt/EBITDA	5.51
Cap/Depr	634.09%
Cap/Sales	6034.22%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.69
Quick Ratio	2.69
Altman-Z	1.44

F-Score3

WACC7.37%

ROIC/WACCN/A

Cap/Depr(3y)253.84%

Cap/Depr(5y)454.19%

Cap/Sales(3y)224.19%

Cap/Sales(5y)422.44%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-480%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-413.7%

EPS Next Y-21.37%

EPS Next 2Y22.06%

EPS Next 3Y29.04%

EPS Next 5YN/A

Revenue 1Y (TTM)61.65%

Revenue growth 3Y1.8%

Revenue growth 5Y81.52%

Sales Q2Q%72.47%

Revenue Next Year13.21%

Revenue Next 2Y38.36%

Revenue Next 3Y34.68%

Revenue Next 5Y23.74%

EBIT growth 1Y-255.81%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year333.37%

EBIT Next 3Y94.4%

EBIT Next 5YN/A

FCF growth 1Y-801.61%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-232.15%

OCF growth 3YN/A

OCF growth 5YN/A

NORTHERN DATA AG / NB2.DE FAQ

What is the ChartMill fundamental rating of NORTHERN DATA AG (NB2.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to NB2.DE.

Can you provide the valuation status for NORTHERN DATA AG?

ChartMill assigns a valuation rating of 1 / 10 to NORTHERN DATA AG (NB2.DE). This can be considered as Overvalued.

What is the profitability of NB2 stock?

NORTHERN DATA AG (NB2.DE) has a profitability rating of 1 / 10.

What is the earnings growth outlook for NORTHERN DATA AG?

The Earnings per Share (EPS) of NORTHERN DATA AG (NB2.DE) is expected to decline by -21.37% in the next year.

NORTHERN DATA AG (NB2.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

NORTHERN DATA AG / NB2.DE FAQ

What is the ChartMill fundamental rating of NORTHERN DATA AG (NB2.DE) stock?

Can you provide the valuation status for NORTHERN DATA AG?

What is the profitability of NB2 stock?

What is the earnings growth outlook for NORTHERN DATA AG?